Tissue Regenix says recent growth ‘is sustainable’ after commercial reorganisation

Tissue Regenix Group PLC chief executive Danny Lee and finance chief David Cocke chatted with Proactive London about the strong revenue growth in the first half of the year and the extra capacity from the expansion of its San Antonio facility.

The company saw increased revenues in its key BioRinse and dCELL products, and Lee said the board believes this growth is sustainable.

David Cocke, chief financial officer, also extolled the benefits of a commercial reorganisation, compressing three layers of management into one, as well as the Phase 1 expansion at San Antonio, and what the effects have been.

You might like

© 2022 Stockmark.it The Latest StockMarket News and Interviews